Skip to content

Improving Adherence to Web-Based Cessation Programs: A Social Network Approach

Improving Adherence to Web-Based Cessation Programs: A Social Network Approach

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01544153
Enrollment
5292
Registered
2012-03-05
Start date
2012-02-29
Completion date
2017-08-31
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Web based behavioral intervention, Adherence, Smoking cessation, Social network, Nicotine replacement therapy, Social support

Brief summary

This study will compare the efficacy of an interactive, evidence-based smoking cessation website (WEB) alone and in conjunction with 1) a theory-driven, empirically-informed social network (SN) protocol designed to integrate participants into the online community, and 2) access to a 4-week supply of free NRT.

Detailed description

This study will compare the efficacy of an interactive, evidence-based smoking cessation website (WEB) alone and in conjunction with 1) a theory-driven, empirically-informed social network (SN) protocol designed to integrate participants into the online community, and 2) access to a 4-week supply of free NRT. Using a 2 (SN integration, no SN) x 2 (access to free NRT, no access) randomized, controlled factorial design with repeated measures at baseline, 3, and 9 months, this study will recruit N=5,000 new members of a Web-based smoking cessation program and randomize them to: 1) WEB, 2) WEB+SN, 3) WEB+NRT, or 4) WEB+SN+NRT. Aim 1: To evaluate the comparative efficacy of WEB+SN, WEB+NRT, and WEB+SN+NRT versus WEB alone with regard to self-reported 30-day point prevalence abstinence at the primary endpoint of 9 months and at secondary endpoint of 3 months. Hypothesis 1a: All three intervention conditions will outperform WEB. Hypothesis 1b: WEB+SN+NRT will outperform WEB+SN and WEB+NRT. Aim 2: To examine whether the impact of treatment condition on cessation is mediated by greater adherence to problem solving/skills training tools, social support, and pharmacotherapy. Hypothesis 2: WEB+SN+NRT will have the greatest impact on treatment adherence, which will yield higher quit rates than the other treatments. Exploratory Aim: To advance theory and identify the processes through which social network integration and provision of free NRT influence treatment adherence. Specifically, exploratory analyses will examine whether social support and social norms are active elements in the pathway to adherence, along with other known mediators of abstinence such as self-efficacy.

Interventions

BEHAVIORALWEB

Usual services available through www.BecomeAnEX.org, a publicly available, evidence-based smoking cessation website.

BEHAVIORALSocial Network

Proactive communications from established members of the community (Integrators) designed to integrate study participants into the online social network on BecomeAnEX.org.

BEHAVIORALNicotine Replacement Therapy (NRT)

A free 4-week supply of nicotine replacement therapy (patch, gum, or lozenge), provided as an over-the-counter product, meaning that no additional support or guidance will be provided to parallel the experience subjects would have if they purchased NRT on their own.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Truth Initiative
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years and older * Current smoker * Registered user on BecomeAnEX.org

Exclusion criteria

* Pregnant or breastfeeding * Cardiovascular conditions * Current use of any stop smoking medication

Design outcomes

Primary

MeasureTime frameDescription
Self-reported 30-day Point Prevalence Abstinence9 months post-randomizationIn the past 30 days, have you smoked any cigarettes at all, even a puff? Number of participants responding No, 30day point prevalence abstinence.

Secondary

MeasureTime frameDescription
Self-reported 30-day Point Prevalence Abstinence3 months post-randomizationIn the past 30 days, have you smoked any cigarettes at all, even a puff? Number of participants responding No, 30day point prevalence abstinence

Countries

United States

Participant flow

Participants by arm

ArmCount
WEB Only
Control group receiving no additional intervention WEB: Usual services available through www.BecomeAnEX.org, a publicly available, evidence-based smoking cessation website.
1,337
WEB+SN
WEB: Usual services available through www.BecomeAnEX.org, a publicly available, evidence-based smoking cessation website. Social Network: Proactive communications from established members of the community (Integrators) designed to integrate study participants into the online social network on BecomeAnEX.org.
1,323
WEB+NRT
WEB: Usual services available through www.BecomeAnEX.org, a publicly available, evidence-based smoking cessation website. Nicotine Replacement Therapy (NRT): A free 4-week supply of nicotine replacement therapy (patch, gum, or lozenge), provided as an over-the-counter product, meaning that no additional support or guidance will be provided to parallel the experience subjects would have if they purchased NRT on their own.
1,313
WEB+SN+NRT
WEB: Usual services available through www.BecomeAnEX.org, a publicly available, evidence-based smoking cessation website. Social Network: Proactive communications from established members of the community (Integrators) designed to integrate study participants into the online social network on BecomeAnEX.org. Nicotine Replacement Therapy (NRT): A free 4-week supply of nicotine replacement therapy (patch, gum, or lozenge), provided as an over-the-counter product, meaning that no additional support or guidance will be provided to parallel the experience subjects would have if they purchased NRT on their own.
1,317
Total5,290

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyNon-smoker0010
Overall StudyUnder 180100

Baseline characteristics

CharacteristicTotalWEB OnlyWEB+SNWEB+NRTWEB+SN+NRT
Age, Customized
18-24 years old
548 Participants131 Participants128 Participants140 Participants149 Participants
Age, Customized
< 18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Customized
25-44 years old
2395 Participants573 Participants615 Participants601 Participants606 Participants
Age, Customized
45-64 years old
2121 Participants567 Participants522 Participants522 Participants510 Participants
Age, Customized
>=65 years
226 Participants66 Participants58 Participants50 Participants52 Participants
Education
College Graduate
1212 Participants309 Participants315 Participants303 Participants285 Participants
Education
High School Graduate
1200 Participants319 Participants279 Participants293 Participants309 Participants
Education
Some College
2631 Participants643 Participants672 Participants658 Participants658 Participants
Education
Some High School or Less
247 Participants66 Participants57 Participants59 Participants65 Participants
Education
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Employment
Employed Full-Time
2402 Participants597 Participants614 Participants608 Participants583 Participants
Employment
Not Employed Full-Time
2888 Participants740 Participants709 Participants705 Participants734 Participants
Employment
Unkown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Marital Status
Has a Partner
2735 Participants695 Participants714 Participants665 Participants661 Participants
Marital Status
No Partner
2555 Participants642 Participants609 Participants648 Participants656 Participants
Marital Status
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
114 Participants34 Participants18 Participants29 Participants33 Participants
Race/Ethnicity, Customized
Asian
82 Participants14 Participants25 Participants17 Participants26 Participants
Race/Ethnicity, Customized
Black or African American
802 Participants216 Participants193 Participants209 Participants184 Participants
Race/Ethnicity, Customized
Hispanic or Latino
294 Participants80 Participants82 Participants61 Participants71 Participants
Race/Ethnicity, Customized
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
55 Participants13 Participants14 Participants14 Participants14 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
4996 Participants1257 Participants1241 Participants1252 Participants1246 Participants
Race/Ethnicity, Customized
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
White
4237 Participants1060 Participants1073 Participants1044 Participants1060 Participants
Region of Enrollment
United States
5290 participants1337 participants1323 participants1313 participants1317 participants
Sex/Gender, Customized
Female
3217 Participants822 Participants809 Participants788 Participants798 Participants
Sex/Gender, Customized
Male
2073 Participants515 Participants514 Participants525 Participants519 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 1,3370 / 1,3244 / 1,3140 / 1,317
serious
Total, serious adverse events
0 / 1,3370 / 1,3240 / 1,3140 / 1,317

Outcome results

Primary

Self-reported 30-day Point Prevalence Abstinence

In the past 30 days, have you smoked any cigarettes at all, even a puff? Number of participants responding No, 30day point prevalence abstinence.

Time frame: 9 months post-randomization

Population: Intent to treat

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
WEB OnlySelf-reported 30-day Point Prevalence Abstinence166 Participants
WEB+SNSelf-reported 30-day Point Prevalence Abstinence146 Participants
WEB+NRTSelf-reported 30-day Point Prevalence Abstinence182 Participants
WEB+SN+NRTSelf-reported 30-day Point Prevalence Abstinence184 Participants
Secondary

Self-reported 30-day Point Prevalence Abstinence

In the past 30 days, have you smoked any cigarettes at all, even a puff? Number of participants responding No, 30day point prevalence abstinence

Time frame: 3 months post-randomization

Population: Intent to treat

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
WEB OnlySelf-reported 30-day Point Prevalence Abstinence164 Participants
WEB+SNSelf-reported 30-day Point Prevalence Abstinence129 Participants
WEB+NRTSelf-reported 30-day Point Prevalence Abstinence190 Participants
WEB+SN+NRTSelf-reported 30-day Point Prevalence Abstinence201 Participants

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026